Published by mark itwired
Posted on September 20, 2021
4 min readLast updated: February 5, 2026
The automated breast ultrasound systems market is set to grow at 8.1% CAGR by 2025, driven by rising breast cancer cases and tech advances.
The global automated breast ultrasound system market will exhibit a volume CAGR of 8.1% through 2025, according to a new analytical research study of FMI. The report estimates the global automated breast ultrasound system market to reach nearly US$ 212.4 Mn in revenues by 202%-end.
With the rapid and wide spread of the coronavirus pandemic, the automated breast ultrasound system market is facing a moderate slump in the short term. Breast ultrasound procedures are largely considered to be elective procedures, which have been postponed during the pandemic to minimize the risk of the contagion. This trend will reduce demand in the near future. However, automation tech helps in remote screening solutions, which could potentially sustain operations during the crisis period.
“Factors such as increased cases of obesity, hormone replacement therapies, age risks, and drop in childbirth, have increased rates of breast cancer in recent years. Consequently, the demand for automated breast ultrasound systems has gone up significantly. These trends are likely to continue into the foreseeable future,” says the FMI analyst.
For more insights into the Market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-606
The ongoing coronavirus pandemic is expected to have a moderate impact on the operations of the automated breast ultrasound systems market. Most countries have designated breast ultrasound procedures as electives, and are encouraging patients and healthcare professionals to postpone such activities for non-urgent cases, for the near future, in a bid to restrict the spread of the contagion. Recovery of the market is likely to be strong owing to the rising global number of breast cancer cases.
Request the Coronavirus Impact Analysis across Industries and Markets@ https://www.futuremarketinsights.com/covid19/rep-gb-606
Breast cancer has prevailed as most commonly diagnosed cancer type, and has become the second leading cause of mortality among women, according to statistics unveiled by National Breast Cancer Foundation. With growing awareness about breast cancer, number of screening procedures has proliferated, thereby propelling demand for advanced diagnostic and follow-up care technologies such as automated breast ultrasound systems in diagnostic centers and hospitals. Facilitated screening of denser breast’s tissues, along with the provision of superior image quality, has offered automated breast ultrasound system (ABUS) a competitive edge over the handheld ultrasound system (HHUS).
The automated breast ultrasound system market comprises players including but not limited to SonoCine Inc., GE Electric Co., Hitachi Ltd., and Siemens AG. Market players are pushing for product launches with tech advancements. For instance, GE Healthcare has developed an FDA-approved, automated breast ultrasound systems aimed towards the diagnosis of cancer in dense breast tissue.
For critical insights on this market, request for Methodology here https://www.futuremarketinsights.com/ask-question/rep-gb-606
The post Automated Breast Ultrasound Systems Market: Notable Developments and Geographical Outlook first appeared on Market Research Blog.
The article discusses the growth and trends in the automated breast ultrasound systems market.
Rising breast cancer cases and advancements in cancer detection technologies are major growth drivers.
COVID-19 has caused a moderate impact, with elective procedures being postponed.
Explore more articles in the Research Reports category
